Watch Ticker

Veru Inc.

Go to Veru Inc. Website

$0.52

0.04 (7.68%)

Live

Previous Close

$0.4804

Day Range

$0 - $0

Previous Day Range

$0.4804 - $0.5004

Market Cap

$72.3 million USD

Day Vol.

Previous Day Vol.

691839

Currency

USD

Primary Exchange

Nasdaq

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the mana...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Lekha Gupta - Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline

Veru sells its FC2 Female Condom business for $18 million, reducing its workforce by 90% and refocusing on its biopharma pipeline, including late-stage trials for enobosarm to treat weight loss in GLP-1-treated patients.

Related tickers: VERU.

Read Full Article

N/A - Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business

Veru Inc. has sold its FC2 Female Condom business for $18 million, allowing the company to focus on its late-stage biopharmaceutical pipeline, including a Phase 2b clinical trial evaluating enobosarm to preserve muscle and augment fat loss in patients receiving the GLP-1 receptor agonist Wegovy.

Related tickers: VERU, NVO.

Read Full Article

Trending Tickers

Please sign in to view